Filling the gap between guidelines and clinical practice in heart failure treatment - Still a far cry from reality

European Journal of Heart Failure

Volumn 9, Issue 12, 2007, Pages 1143-1145

  Remme, Willem J ^a  

^a Sticares Cardiovascular Research Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; NITRATE; SPIRONOLACTONE;

AGE; DISEASE SEVERITY; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 36348968971     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.08.005     Document Type: Editorial

References (23)

1. CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure. Results of the North Scandinavian enalapril survival study. N Engl J Med 316 (1987) 1429-1435
2. Cohn J.N., Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 (1991) 303-310
3. The Solvd Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
4. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334 (1996) 1349-1355
5. CIBIS II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 353 (1999) 9-13
6. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
7. Packer M., Coats A.J.S., Fowler M.B., et al., for the Carvedilol Prospective Randomized Cumulative Survival Study Group (COPERNICUS). Effect of carvedilol on survival in severe chronic heart failure. New Engl J Med 344 (2001) 1651-1658
8. Pitt B., Zannad F., Remme W.J., Rody R., Castaigne A., Perez A., Palensky J., Wittes J., and for the Randomized Aldactone Evaluation Study (RALES) Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 341 (1999) 709-717
9. Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 (2003) 759-766
10. The Solvd Investigators. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (1992) 685-691
11. Remme W.J., and for the Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Guidelines for the treatment of heart failure. Eur Heart J 18 (1997) 736-753
12. Remme W.J., and Swedberg K., Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
13. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 26 (2005) 1115-1140
14. Cleland J.G., Cohen-Solal A., Cosin Aguilar J., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360 (2002) 1631-1639
15. Komajda M., Follath F., Swedberg K., et al., for the Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Eur Heart J 24 (2003) 464-474
16. Komajda M., Lapuerta P., Hermans N., et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER study. Eur Heart J 26 (2005) 1653-1659
17. De Groote P., Isnard R., Assyag P., et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from IMPACT RECO survey. Eur J Heart Fail 9 (2007) 1205-1211 (this issue)
18. Komajda M., Bouhour J.B., Amouyel P., et al. Ambulatory heart failure management in private practice in France. Eur Heart J 3 (2001) 503-507
19. Jullien G., Fraboulet J.Y., Poncelet P., et al. Registry of cardiac insufficiency in cardiology. Arch Mal Coeur Vaiss 94 (2001) 1351-1356
20. Cohen-Solal A. Management of heart failure by general practitioners in France. Results of the study IMPROVEMENT of heart failure (IMPROVEMENT-HF). Arch Mal Coeur Vaiss 95 Spec 4 (2002) 11-15
21. Houpe D., Peltier M., Cohen-Solal A., et al. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year. Int J Cardiol 103 (2005) 286-292
22. Flather M.D., Shibata M.C., Coats A.J., et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225
23. Kotlyar E., Keoch A.M., Macdonald P.S., Arnold R.H., McCaffrey D.J., and Glanville A.R. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. J Heart Lung Transplant 12 (2002) 1290-1295